Dianthus Therapeutics (DNTH) Misses Q4 EPS by 143c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q4 EPS of ($1.43). Revenue for the quarter came in at $280 thousand.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• S&P Global (SPGI) Declares $0.97 Quarterly Dividend; 1% Yield
• Boeing wins $121 million Navy contract for P-8A upgrades